The Russian Direct Investment Fund (RDIF) has asked the Slovak government to return the lot Sputnik-V vaccines because he repeatedly violated the terms of the contract, so that these vaccines are available in other countries, according to a statement posted on the official Twitter account of the Russian vaccine.
The RDIF made this request following doubts raised by the Slovak National Medicines Agency as to whether the vaccine met the requirements of the European Medicines Agency (EMA) and data published in The Lancet.
The Russian Direct Investment Fund (RDIF), in its statement, asked the Slovak government to send the vaccine for certification to the EU laboratory for testing and on April 6 sent a letter requesting that the vaccine be returned due to the numerous breaches of contract terms to be used in other countries.
Earlier, Magdalena Jürkemikova, secretary of the State Drug Control Institute (Slovak National Drug Agency), said that the Russian vaccine against coronavirus Sputnik-V, the first batch of which arrived in Slovakia on March 1, had not been received. published in the prestigious medical journal The Lancet but also in the data of the European Medicines Agency (Coreper).